₹10,000 Monthly SIP in Nippon India Pharma Fund-Growth Plan for 5 Years
If you had started a ₹10,000/month SIP on 30 Sept 2021 and never stopped — through every crash and rally — here is exactly what happened, using Nippon India Pharma Fund-Growth Plan's actual NAV for all 61 installments.
You invested
₹6,10,000
61 installments
Value today
₹9,06,188
30 Sept 2026
Absolute gain
+₹2,96,188
+48.6%
XIRR (annualised)
15.59%
money-weighted
The journey, month by month
Worst fall on the way
-13.4%
Deepest drop from peak. This is what you had to sit through.
Corrections survived
1
Falls of 10%+ during the period. Every one recovered.
Same SIP in a fixed deposit
₹7,18,461
Modelled at historical FD rates. The fund beat FD by ₹1,87,727.
Year-by-year progress
| Year | Invested | Value | Overall gain |
|---|---|---|---|
| Year 1 (30 Sept 2022) | ₹1,30,000 | ₹1,27,523 | -1.9% |
| Year 2 (3 Oct 2023) | ₹2,60,000 | ₹3,12,413 | +20.2% |
| Year 3 (30 Sept 2024) | ₹3,70,000 | ₹6,01,180 | +62.5% |
| Year 4 (30 Sept 2025) | ₹4,90,000 | ₹6,88,890 | +40.6% |
| Year 5 (30 Sept 2026) | ₹6,10,000 | ₹9,06,188 | +48.6% |
Best year of the journey: Year 3 (+42.3% market move) · Toughest year: Year 4 (-4.5%)
Wealth Time Machine
Watch this exact journey as a 60-second cinematic replay
Every crash headline, every recovery — with your money in it.
Try a different amount
Try a different duration
Past performance does not guarantee future returns. This page shows the historical result of the stated SIP using Nippon India Pharma Fund-Growth Plan's published NAV (source: AMFI) between 30 Sept 2021 and 30 Sept 2026; it is educational research, not investment advice. FD comparison is modelled at historical average FD rates. Mutual fund investments are subject to market risks.